Prime Medicine, Inc.
Q3 2026 13F Holders
Symbol
PRME
CUSIP
74168J101
Type
Equity
Class
COM
Num filers
188
Total reported value, excl. options
$377M
Compare 2026 Q3 to
2026 Q2
2026 Q1
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q3
2024 Q2
2024 Q1
2023 Q4
2023 Q3
2023 Q2
2023 Q1
2022 Q4
Excl. options
Options only
All
Manager
Report Date
Value ($000)
Shares
Option Type